IOVA icon

Iovance Biotherapeutics

294 hedge funds and large institutions have $1.86B invested in Iovance Biotherapeutics in 2024 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 114 increasing their positions, 80 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

5.32% more ownership

Funds ownership: 77.77%83.09% (+5.3%)

38% less funds holding in top 10

Funds holding in top 10: 85 (-3)

42% less capital invested

Capital invested by funds: $3.22B → $1.86B (-$1.35B)

Holders
294
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$25.3M
Puts
$18.5M
Net Calls
Net Calls Change

Top Sellers

1 -$22M
2 -$18.7M
3 -$14.3M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$13.6M
5
Millennium Management
Millennium Management
New York
-$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$2M
77
$1.96M
78
$1.95M
79
$1.9M
80
$1.75M
81
$1.72M
82
$1.71M
83
$1.63M
84
$1.61M
85
$1.59M
86
$1.57M
87
$1.5M
88
$1.39M
89
$1.33M
90
$1.32M
91
$1.28M
92
$1.23M
93
$1.17M
94
$1.17M
95
$1.11M
96
$1.1M
97
$1.09M
98
$1.09M
99
$1.06M
100
$1.01M